Sign in

CIK 0001434647

  • Non-accelerated filer
  • Smaller reporting company

ZEVRA THERAPEUTICS, INC.

Sign in to watch
Ticker
ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205894398
Phone
+1 888-958-1253
Business address
101 FEDERAL STREET, BOSTON, MA, 02110
Former names
KEMPHARM, INC, KEMPHARM INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$224,948
in 1 filing, $225K under 10b5-1 plans

Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McFarlane Neil F. −$225K President and CEO sold 5% of stake
Date Insider Transaction Shares Price Value Owned after
2015-04-21 Thompson Danny L Director Conversion · Series A Convertible Preferred Stock −269,959 0
2015-04-21 Thompson Danny L Director Conversion · Series B Convertible Preferred Stock −161,290 0
2015-04-21 Thompson Danny L Director Conversion · Series C Convertible Preferred Stock −256,410 0
2015-04-21 Saluri Joseph Director Conversion +4,555 4,555
2015-04-21 Saluri Joseph Director Conversion · Series B Convertible Preferred Stock −16,130 0
2015-04-21 Saluri Joseph Director Conversion · Series C Convertible Preferred Stock −18,044 0
2015-04-21 Mickle Christal M M VP Operations & Prod Dev Conversion +5,983 277,094
2015-04-21 Mickle Christal M M VP Operations & Prod Dev Conversion +96,288 96,288
2015-04-21 Mickle Christal M M VP Operations & Prod Dev Conversion · Series A Convertible Preferred Stock −527,093 0
2015-04-21 Mickle Christal M M VP Operations & Prod Dev Conversion · Series B Convertible Preferred Stock −6,203 0
2015-04-21 Mickle Christal M M VP Operations & Prod Dev Conversion · Series C Convertible Preferred Stock −51,332 0
2015-04-21 Mickle Christal M M VP Operations & Prod Dev Conversion · Series C Convertible Preferred Stock −44,873 0
2015-04-21 Mickle Christal M M VP Operations & Prod Dev Conversion · Series D Convertible Preferred Stock −137,541 0
2015-04-21 Mickle Christal M M VP Operations & Prod Dev Conversion · Warrant to Purchase Series D Preferred Stock (right to buy) −32,371 $0.78 $25K 0
2015-04-21 Mickle Christal M M VP Operations & Prod Dev Conversion · Warrant to Purchase Common Stock (right to buy) −4,316 4,316
2015-04-21 Plooster Matthew R Director Conversion +4,545 4,545
2015-04-21 Plooster Matthew R Director Conversion +1,117 1,117
2015-04-21 Plooster Matthew R Director Conversion +428,304 428,304
2015-04-21 Plooster Matthew R Director Conversion · Series C Convertible Preferred Stock −25,642 0
2015-04-21 Plooster Matthew R Director Conversion · Series D Convertible Preferred Stock −8,456 0

Page 24 of 25 · 499 trades